Free product worth Rs 499 on all myUpchar products X
Olsavas 3 is a commercial drug that is prescribed in the form of Tablet. Other than this, Olsavas 3 has some other therapeutic uses, which have been discussed ahead.
Medical history of the patient along with age and gender determines the dosage of Olsavas 3. Dosage also depends on the route of administration and your chief complaint for which the drug is prescribed. For detailed information on this, read through the dosage section.
The most common side effects of Olsavas 3 are Upper respiratory tract infection. While these are the most often observed Olsavas 3 side effects, there are can be others also. These have been listed below. These side effects of Olsavas 3 are usually temporary and subside with the completion of treatment. However, if these continue for a longer time, consult your doctor right away.
In addition, Olsavas 3's effect is Safe during pregnancy and Safe for lactating mothers. In addition, Olsavas 3's effects on the liver, heart and kidney are discussed below in the Olsavas 3 related warnings section.
Olsavas 3 is not recommended if you suffer from certain medical conditions as it can have adverse effects. Bradycardia (Slow Heart Rate), Low Blood Pressure (Hypotension), Low Blood Pressure (Hypotension) are examples of such conditions. Other contraindications of Olsavas 3 have been discussed in the sections ahead.
Drug reaction of Olsavas 3 with other medicines has been reported. A complete list of these interactions is given below.
Along with the above-mentioned precautions, remember that taking Olsavas 3 is considered not safe while driving, and is not addictive.
Olsavas 3 is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Adult |
|
Geriatric |
|
Is the use of Olsavas 3 safe for pregnant women?
Pregnant women can take Olsavas 3 without worrying about any side effects.
Is the use of Olsavas 3 safe during breastfeeding?
Olsavas 3 does not show any harmful effects in lactating women.
What is the effect of Olsavas 3 on the Kidneys?
Olsavas 3 rarely harms the kidneys.
What is the effect of Olsavas 3 on the Liver?
Olsavas 3 may have mild side effects on the liver. Most people will never see any effect on the liver.
What is the effect of Olsavas 3 on the Heart?
Olsavas 3 has very mild side effects on the heart.
Olsavas 3 should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
If you are suffering from any of the following diseases, you should not take Olsavas 3 unless your doctor advises you to do so -
Is this Olsavas 3 habit forming or addictive?
Forming a habit of Olsavas 3 has not been reported.
Interaction between Food and Olsavas 3
Eating certain foods may increase the time it takes Olsavas 3 to have an effect. You should consult your doctor about it.
Interaction between Alcohol and Olsavas 3
Consuming Olsavas 3 with alcohol can have many serious effects on your body.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Benicar (olmesartan medoxomil)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 507
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 169-173
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Norvasc® (amlodipine besylate)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 540, 549, 550
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 147-148
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Hydrochlorothiazide
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 582-586
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 446-448